Prawo i regulacje · 22/10/2021

Mycrodose Therapeutics Seeks Registration as Controlled Substance Importer

Mycrodose Therapeutics has submitted an application to the U.S. government to be registered as an importer of controlled substances, a move that could potentially impact the pharmaceutical industry. The company is seeking to import basic classes of controlled substances, and further details can be found in the Supplementary Information section.